Immunocore Holdings (IMCR) Change in Account Payables (2023 - 2025)
Historic Change in Account Payables for Immunocore Holdings (IMCR) over the last 3 years, with Q3 2025 value amounting to -$287000.0.
- Immunocore Holdings' Change in Account Payables rose 6301.55% to -$287000.0 in Q3 2025 from the same period last year, while for Sep 2025 it was $2.0 million, marking a year-over-year decrease of 6091.78%. This contributed to the annual value of $7.3 million for FY2024, which is 17702.86% up from last year.
- Latest data reveals that Immunocore Holdings reported Change in Account Payables of -$287000.0 as of Q3 2025, which was up 6301.55% from -$6.9 million recorded in Q2 2025.
- Over the past 5 years, Immunocore Holdings' Change in Account Payables peaked at $6.0 million during Q2 2023, and registered a low of -$6.9 million during Q2 2025.
- Moreover, its 3-year median value for Change in Account Payables was -$287000.0 (2025), whereas its average is $547545.5.
- Data for Immunocore Holdings' Change in Account Payables shows a peak YoY increase of 24405.17% (in 2025) and a maximum YoY decrease of 25452.72% (in 2025) over the last 5 years.
- Quarter analysis of 3 years shows Immunocore Holdings' Change in Account Payables stood at $3.8 million in 2023, then surged by 56.7% to $5.9 million in 2024, then plummeted by 104.88% to -$287000.0 in 2025.
- Its Change in Account Payables stands at -$287000.0 for Q3 2025, versus -$6.9 million for Q2 2025 and $3.3 million for Q1 2025.